Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Reactogenicity and safety of ChAd155-vectored respiratory syncytial virus (RSV) vaccine (ChAd155-RSV) administered at different dose levels in infants aged 6–7 months

Autor: Pinto, Jorge, Norero, Ximena, Mussi-Pinhata, Marisa Márcia, Merino Arribas, Jose Manuel, Martinón-Torres, Federico, Rämet, Mika, Parra, Mercedes Macias, Luciani, Kathia, Langley, Joanne M, Kuchar, Ernest, Krasnow, Aleksander, Faust, Saul, DİNLEYİCİ, ENER ÇAĞRI, Díez-Domingo, Javier, ÇETİN, BENHUR ŞİRVAN, Castelli Gattinara, Guido, Campbell, James Daniel, D Boucher, Francois, Baquero Artigao, Fernando, Anderson, Evan, Gabriel, Miguel Angel Marin, López-Medina, Eduardo, Seppa, Ilkka, Tapiero, Bruce, Rojo Conejo, Pablo, Szymanski, Henryk, Szenborn, Leszek, Salamanca De La Cueva, Ignacio, Sáez-Llorens, Xavier, Puthanakit, Thanyawee, Dieussaert, Ilse, Friel, Damien, Gonzalez Lopez, Antonio, Mcphee, Roderick, Nikic, Vanja, Stoszek, Sonia K, Woo, Wayne, Vanhoutte, Nicolas, İNCE, OSMAN TOLGA, Ramos Amador, Jose Tomas

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2605::54f88f01cb08a285494caa300be07a16
https://avesis.deu.edu.tr/publication/details/b84c447b-b444-4a30-8903-d5f1db3640a9/oai

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Safety of the adjuvanted recombinant zoster vaccine in adults aged 50 years or older. A phase IIIB, non-randomized, multinational, open-label study in previous ZOE-50 and ZOE-70 placebo recipients

Autor: Dominicus Rolf, Ferrera Giuseppe, Freire Antônio Tarcísio, Lachance Pierre, Patrick Janice, Céline Boutry, Rodríguez de la Pinta Maria Luisa, Schaefer Axel, Hui David Shu Cheong, Schmidt Juergen, Plassmann Georg, Looze de Ferdinandus, Schenkenberger Isabelle, Josephine Ocran-Appiah, Toursarkissian Nicole, Grosskopf Josef, Beytout Jean, Staniscia Tommaso, Zahharova Irina, Klaff Leslie, Wachter Juergen, Kim Hyo Youl, Mueller Michael, Eto Takashi, Barbanti Piero, Lipetz Robert, Virta Miia, Ahonen Anitta, Ogata Hiroaki, Pauksens Karlis, McNally Damien, Grigat Christine, Geller Steven, Bengtsson Niklas, Poder Airi, Wilson Jonathan, Houser Patricia, Hwang Shinn-Jang, Berglund Johan Sanmartin, Jung Thomas, Rombo Lars, Datta Susan, Chlibeck Roman, Schubert Christian, Athan Eugene, Desole Maria Giuseppina, Huong Yieng, Dionne Marc, Stockhausen Juergen, Houle Pierre-Alain, Yunes Elsa Maria, Anne Schuind, Eckermann Tamara, Sueki Hirohiko, Schwarz Tino, Núñez López Concepción, Åke Olsson, Yeo Wilfred, Powell Calvin, Hartley Paul, Gerlach Beatrice, Curiac Dan, Hoeltz-Roehrig Susanne, Suzuki Shin, Mascareñas de Los Santos Abiel, Finneran Matthew, Ellison William, Narejos Pérez Silvia, Caroline Hervé, Pérez Vera Mercè, Powell Stephanie, Berndtsson Blom Katarina, Irimajiri Junya, Aldea Novo Marta, Dahmen Antje, Jacob Wilson, Kuroki Rie, Eizenberg Peter, Seppa Ilkka, Goldani Luciano, McNeil Shelly, Scott John, Liu Bo, Downey Herman Jackson, Andrews Charles, Caso Covadonga, Cunningham Anthony L, Toma Azhar, Lee Jacob, Ferguson Murdo, Weckx Lily, Berger-Roscher Juergen, Sauter Joachim, Park Dae Won, Forsten Aino, Barba-Gómez Jose-Fernando, Migliorino Guglielmo, Horacek Thomas, Levin Michael, Rosen Robert, Brotons Cuixart Carles, Koskinen Pekka, Schmitt Bernhard, Linnhoff Anneliese, Koenig Hans-Joachim, Tinoco Juan Carlos, Ghesquiere Wayne, Song Young Goo, Gauthier Jean-Sebastien, Icardi Giancarlo, Kokko Satu, Sha Edmund Kwok Yiu, Nakamura Kenjiro, Diez-Domingo Javier, Choo Eun-Ju, Lundvall Martin, Munir Abul Kashem, Jyoti Soni, Esen Meral, Arya Mark, Moeckesch Beate, Heaton Ken, Malempati Srikanth, Ervin John, Naritomi Yuji, Gorfinkel Iris, Manning Mary Beth, Tellier Guy, Poling Terry, Lee Jin-Soo

Publikováno v: Vaccine. 39(1)

Background Efficacy of the adjuvanted recombinant zoster vaccine (RZV) against herpes zoster (HZ) was demonstrated in pivotal trials ZOE-50 (NCT01165177) and ZOE-70 (NCT01165229). This study was designed to offer RZV to placebo recipients of these pa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70e06a6d48e23064a25f46f9a3b63c11
https://pubmed.ncbi.nlm.nih.gov/33277059

Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label, multi-center study.

Autor: Piazza, Franco M., Virta, Miia, Paassilta, Marita, Ukkonen, Benita, Ahonen, Anitta, Esteves-Jaramillo, Alejandra, Forsten, Aino, Seppa, Ilkka, Ding, Jian, Neveu, David, Jordanov, Emilia, Dhingra, Mandeep S.

Publikováno v: Human Vaccines & Immunotherapeutics; 2022, Vol. 18 Issue 1, p1-10, 10p